Results 191 to 200 of about 2,889,207 (269)

Formerly incarcerated patient care in student-run clinics: substance use patterns and opportunities for intervention. [PDF]

BMC Public Health
Raturi V, Watts H, Stall T, Terry E, Personius L, Metz D, Sekou H, Niyogi A, Ratakonda S, Power C, Pope H.   +10 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

A Disputed Hegemony: Negotiating Neurosurgical Patient Care in the Netherlands, 1930-1952. [PDF]

J Hist Med Allied Sci
Lutters B.
europepmc   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

Molecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park, Kyongman An, Gyeonghwa Kim, Soo‐Nyun Choi, Hong‐Ki Lee, Keun Hur, Kyu‐Shik Jeong   +6 more
wiley   +1 more source

Determinants of self-monitoring adherence in type 2 diabetes: bridging the gap in patient care. [PDF]

Front Public Health
Hyassat D, Alonezat K, Abdalrahim M, Batieha A, Khader Y, Alnsour S, Al-Qalalweh SB, Ajlouni K.   +7 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Telemedicine-assisted point-of-care ultrasound to improve the quality of patient care in rural areas. [PDF]

Ultrasonography
Kleemann T, Freund R, Müller D, Güther C, Duma A, Mohamed A, Tran QT, Löbel M, Pannach S, Briesemann D, Diepelt T, Aretakis D, Wree A, Tacke F, Ortmann S, Schulz M.   +15 more
europepmc   +1 more source

Molecular Tumor Boards clinical impact on patient care and structural features: A systematic review and meta-analysis. [PDF]

PLoS Med
Russo L, Giacobini E, Lentini N, Osti T, Kamal M, Boccia S, Pastorino R.   +6 more
europepmc   +1 more source

Internal Medicine Residents' Challenges in Trauma-Informed Care and Impact on Patient Care: A Multiple-Methods Study. [PDF]

J Gen Intern Med
Thachapuzha U, Jean-Jacques M, Chuzi S, Chakraborty Y, Singh R, Mokhtar IB, Kaat AJ, Ganatra S, O'Conor R, Pierre-Wright M.   +9 more
europepmc   +1 more source

Erratum: AI in hematology: A new frontier for nursing practice and patient care. [PDF]

J Family Med Prim Care
europepmc   +1 more source